Form 4 for EW Edwards Lifesciences
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-17 · accession 0001225208-23-000678 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-17 | 2023-01-17 | EW | Chopra Daveen | CVP, TMTT | S - Sale+OE | $78.00 | -4,000 | 18.9K | -17% | -$312.0K |
| D | 2023-01-17 | 2023-01-17 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $45.28 | +4,000 | 22.9K | +21% | +$181.1K |
| D | 2023-01-17 | 2023-01-17 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $0.00 | -4,000 | 8,435 | -32% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-17 | S | D | 4,000 | $78.00 | 18,911 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-17 | M | A | 4,000 | $45.28 | 22,911 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2023-01-17 | M | D | 4,000 | $0.00 | 8,435 | D | $45.28 · 2019-05-17 to 2025-05-16 | 4,000 Common Stock |